Global Bipolar Disorder Therapeutic Market Growth 2023-2029

Global Bipolar Disorder Therapeutic Market Growth 2023-2029

Bipolar disorder, also known as manic-depressive disorder, is a mental illness. It is a mental health problem that primarily affects mood. Symptoms of bipolar disorder are extreme irritability or agitation, a period of feeling empty, loss of interest in normal activities, sleep problems, etc. According to Pfizer, Inc., bipolar disorder affects over 5 million people in the U.S. Bipolar episodes are characterized by a drastic change in behavior and mood, and range from joyful and overexcited (manic episodes) to extremely sad and hopeless (depressive state). These disorders have different types of episodes such as manic episodes, hypomanic episodes, depressive episodes, and mixed episodes. Causes of bipolar disorders include childhood trauma, stressful life events, self-esteem problems, and genetic inheritance. People across the world marked “March 30” as a World Bipolar Day to spread awareness about the disorder and erase the stigma of mental illness. Large number of people suffering from this mental condition resort to drinking to lift their mood. According to the National Institute on Alcohol Abuse and Alcoholism, 27.6% of the people with bipolar disorder become addicted to alcohol, while over 16% engaged in alcohol abuse.

LPI (LP Information)' newest research report, the “Bipolar Disorder Therapeutic Industry Forecast” looks at past sales and reviews total world Bipolar Disorder Therapeutic sales in 2022, providing a comprehensive analysis by region and market sector of projected Bipolar Disorder Therapeutic sales for 2023 through 2029. With Bipolar Disorder Therapeutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bipolar Disorder Therapeutic industry.

This Insight Report provides a comprehensive analysis of the global Bipolar Disorder Therapeutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bipolar Disorder Therapeutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Bipolar Disorder Therapeutic market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bipolar Disorder Therapeutic and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bipolar Disorder Therapeutic.

The global Bipolar Disorder Therapeutic market size is projected to grow from US$ 3771.5 million in 2022 to US$ 4362.3 million in 2029; it is expected to grow at a CAGR of 4362.3 from 2023 to 2029.

The growing need to reduce the financial burden of bipolar disorder will drive the growth prospects for the global bipolar disorder therapeutic market until the end of 2021. It has been observed that governments and companies across the globe are increasingly organizing awareness camps to raise disease awareness among the public, reduce the burden of mental disorders in vulnerable groups, ensure the rights of people with mental disorders, and make treatment facilities accessible to them. Consequently, such awareness initiatives help to curb the overall monetary loss, reduce their effect on the global economy, and improve the quality of life for patients. Such factors will raise public awareness about mental disorders and treatments and in turn, propel the rate of revenue generation in the market.

This report presents a comprehensive overview, market shares, and growth opportunities of Bipolar Disorder Therapeutic market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Antipsychotics
Anticonvulsants
Mood Stabilizers

Segmentation by application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Allergan
Astellas Pharma
GlaxoSmithKline
Janssen Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Bipolar Disorder Therapeutic market?

What factors are driving Bipolar Disorder Therapeutic market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Bipolar Disorder Therapeutic market opportunities vary by end market size?

How does Bipolar Disorder Therapeutic break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.